iGMDRD817


Loading, please wait...
Standard Name
Drug Status
Drug Type
Standard NameAnti-ERBB3 Agents
Drug StatusClassification
Drug TypeTherapy

Drug-model tissue-cancer distribution: Bubble Plot

OVARtissue: OVAR cancer: OVARY model num: 0OVARYtissue: OVARY cancer: Ovarian Cancer model num: 1

Drug-gene pathway enrichments

2reactome: SHC1 events in ERBB2 signaling2reactome: Signaling by Receptor Tyrosine Kinases2reactome: Signaling by ERBB42reactome: Signal Transduction2reactome: Signaling by ERBB21wikipathways: MicroRNAs in cardiomyocyte hypertrophy1wikipathways: Cardiac Progenitor Differentiation1wikipathways: Cardiac Hypertrophic Response1pharmgkb: EGFR Inhibitor Pathway, Pharmacodynamics1reactome: Signaling by Non-Receptor Tyrosine Kinases

Drug-gene GO enrichments

2BP: nervous system development2BP: activation of transmembrane receptor protein tyrosine kinase activity2CC: extracellular region2BP: ERBB signaling pathway1BP: positive regulation of striated muscle cell differentiation1BP: negative regulation of secretion1BP: positive regulation of peptidyl-tyrosine phosphorylation1BP: positive regulation of protein kinase B signaling1BP: cardiac muscle cell differentiation1BP: oligodendrocyte differentiation

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
3084 NRG1 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Models in Anti-ERBB3 Agents

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​